Your Location：
Home >
Browse articles >
Evaluation on Kang'ai Injection Combined with Chemoradiation Scheme for Treating Middle-late Esophageal Cancer
Evaluation on Kang'ai Injection Combined with Chemoradiation Scheme for Treating Middle-late Esophageal Cancer
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 19, Issue 10, Pages: 337-339(2013)
DOI： 10.11653/syfj2013100337
Scan QR Code
Full Text(HTML)
References
Publication Info
Metrics
53
Views
40
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Qige San Regulates miR-133a/PI3K/Akt Signaling Pathway-mediated Tumor Angiogenesis to Treat Esophageal Cancer
Traditional Chinese Medicine Treats Esophageal Cancer via PI3K/Akt Signaling Pathway： A Review
Baitouweng Tang Inhibits Growth of Esophageal Cancer Cells Through BUB1/STAT3 Signaling Pathway
Chinese Medicine Regulates Signaling Pathways Related to Esophageal Cancer： A Review
Role of NF-κB Signaling Pathway in "Reflux Esophagitis-esophageal Cancer" and Traditional Chinese Medicine Intervention：A Review
Related Author
HAN Yuhui
GAO Xiaoling
LI Dandan
LIU Xianghua
WEI Yumeng
CHEN Yulong
GUO Wei
PENG Chen
Related Institution
Henan University of Chinese Medicine
The First Clinical Medical School of Henan University of Chinese Medicine
The First Affiliated Hospital of Henan University of Chinese Medicine
School of Medicine，Henan University of Chinese Medicine
Henan Key Laboratory of Traditional Chinese Medicine（TCM） Syndrome and Prescription in Signaling， Henan International Joint Laboratory of TCM Syndrome and Prescription in Signaling， TCM School， Henan University of Chinese Medicine
Chat
